Last reviewed · How we verify
NCT04439812
Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer
trial testing Observation in Stomach Neoplasms in 267 participants. Completed in 31 December 2018.
31 December 2018
Quick facts
| Lead sponsor | Hospital Universitario Ramon y Cajal |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 267 |
| Start date | 1 January 2010 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2018 |
Drugs / interventions tested
- Observation
Conditions studied
- Stomach Neoplasms — all drugs for Stomach Neoplasms →
Sponsor
Hospital Universitario Ramon y Cajal
Who can join
Eligibility, any sex, with Stomach Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Incidence of positive surgical margins after curative gastrectomy ranges from 1% to 20%. It has been suggested that positive surgical margins is an adverse prognosis factor, with a higher local recurrence and worse overall survival (OS). However, the management of these patients remains unclear.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04439812
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observation
Trials testing the same drug.
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
- NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
- NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
- NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
- NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting
Other recruiting trials for Stomach Neoplasms
Currently open trials in the same condition.
- NCT07482566 — Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer · NA · recruiting
- NCT06885697 — Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi · Phase 1 · recruiting
- NCT07504913 — Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41 · recruiting
- NCT07113340 — Carina™ Surgical Platform for Minimal Radical Gastrectomy · NA · active not recruiting
- NCT06630130 — Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer · Phase 2 · recruiting
Other Hospital Universitario Ramon y Cajal trials
Trials by the same sponsor.
- NCT07001215 — Effect of CPAP Versus APAP in Patients With Obesity Undergoing Bariatric Surgery Protocol · NA · not yet recruiting
- NCT05268471 — Cost-effectiveness Analysis and Conditional Response to the Effect of Positional Devices in Obstructive Sleep Apnea · NA · unknown
- NCT04690179 — Effects of Sarcopenia and Sarcopenic Obesity in Complex Abdominal Wall Surgery · unknown
- NCT05435521 — Impact of a Personalized Multicomponent Exercise Program in Real Conditions Among Older Adults With HIV · NA · unknown
- NCT04935450 — Pulmonary Inflammation in COVID-19 ARDS · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04439812 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Ramon y Cajal
- Last refreshed: 19 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04439812.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing